another SCRC article on the worldwide web!! Go SCR
Post# of 7769
Posted On: 12/18/2014 5:41:30 PM
another SCRC article on the worldwide web!! Go SCRC! Tut
http://www.microcapdaily.com/is-this-rebounci...crc/17847/
ScripsAmerica, Inc. (OTCMKTS:SCRC) highly efficient marketing and distribution platform provides their clients with competitive pricing and seamless access to a broad customer base. SCRC has built strong relationships across the entire drug distribution chain, from the wholesalers and manufacturers to the end distribution outlets, allowing it to achieve minimum turn-around time and maximum shelf-life for its products.
SCRC has been putting out a number of significant press releases in recent weeks including the one on June 3 that started it all; they announced that the Company has begun discussions with Forbes Investment Ltd. to market, supply, distribute and adapt its RapiMed(R) products throughout China. According to Kline and Company, the Chinese OTC market is valued at over $32 Billion Dollars.
To Find out the inside Scoop on SCRC Subscribe to Microcapdaily.com Right Now by entering your Email in the box below
Jun Liang, Manager of Forbes Ltd. in Shenzhen, China, is arranging for ScripsAmerica to meet with its pharmacy and hospital buying networks as part of an upcoming sales agreement that would introduce RapiMed(R) into the Chinese OTC drug market. Liang said, “ScripsAmerica’s RapiMed Products are uniquely formulated to meet China’s market needs. It allows the country’s pharmaceutical companies, hospitals, nursing facilities, research institutes and the military to adapt RapiMed to fit their situations.”
On October 6 SCRC announced that the Company’s managed specialty pharmacy reported $5,457,137 in approved orders during the month of September 2014. The pharmacy’s September revenue represented a 12% increase over the previous month and increased its annual run rate to over $65 million.
http://www.microcapdaily.com/is-this-rebounci...crc/17847/
ScripsAmerica, Inc. (OTCMKTS:SCRC) highly efficient marketing and distribution platform provides their clients with competitive pricing and seamless access to a broad customer base. SCRC has built strong relationships across the entire drug distribution chain, from the wholesalers and manufacturers to the end distribution outlets, allowing it to achieve minimum turn-around time and maximum shelf-life for its products.
SCRC has been putting out a number of significant press releases in recent weeks including the one on June 3 that started it all; they announced that the Company has begun discussions with Forbes Investment Ltd. to market, supply, distribute and adapt its RapiMed(R) products throughout China. According to Kline and Company, the Chinese OTC market is valued at over $32 Billion Dollars.
To Find out the inside Scoop on SCRC Subscribe to Microcapdaily.com Right Now by entering your Email in the box below
Jun Liang, Manager of Forbes Ltd. in Shenzhen, China, is arranging for ScripsAmerica to meet with its pharmacy and hospital buying networks as part of an upcoming sales agreement that would introduce RapiMed(R) into the Chinese OTC drug market. Liang said, “ScripsAmerica’s RapiMed Products are uniquely formulated to meet China’s market needs. It allows the country’s pharmaceutical companies, hospitals, nursing facilities, research institutes and the military to adapt RapiMed to fit their situations.”
On October 6 SCRC announced that the Company’s managed specialty pharmacy reported $5,457,137 in approved orders during the month of September 2014. The pharmacy’s September revenue represented a 12% increase over the previous month and increased its annual run rate to over $65 million.
(0)
(0)